Binding properties of the human immunodeficiency virus type 1 nucleocapsid protein p7 to a model RNA: elucidation of the structural determinants for function - PubMed (original) (raw)
. 1999 Mar 19;287(1):59-75.
doi: 10.1006/jmbi.1998.2521.
Affiliations
- PMID: 10074407
- DOI: 10.1006/jmbi.1998.2521
Binding properties of the human immunodeficiency virus type 1 nucleocapsid protein p7 to a model RNA: elucidation of the structural determinants for function
M A Urbaneja et al. J Mol Biol. 1999.
Abstract
HIV-1 nucleocapsid protein (NCp7) is a double zinc-fingered protein that has been traditionally implicated in viral RNA recognition and packaging, in addition to its tight association with genomic RNA and tRNA primer within the virion nucleocapsid. The availability of large quantities of viral or recombinant wild-type NCp7 and mutant p7 has made possible the assignment of the different roles that structural motifs within the protein play during RNA binding. At low ionic strength binding to the homopolymeric fluorescent RNA, poly(epsilonA), is electrostatically driven and four sodium ions are displaced. Arg7 in the flanking N-terminal region, Lys20 and Lys26 in the first zinc finger and one positively charged residue (attributed to Lys41) in the second zinc finger are involved in electrostatic contacts with RNA. The p7 zinc fingers do not function independently but concomitantly. The first zinc finger (both isolated or in the context of the full-length protein) has a more prominent electrostatic interaction than the second one. The second zinc finger dominates the non-electrostatic stabilization of the binding to RNA due to stacking of its Trp residue with nucleic acid bases. Mutations in the highly conserved retroviral Zn-coordinating residues (CCHC) to steroid hormone receptor (CCCC) or transcription factor (CCHH) metal cluster types do not affect RNA binding. In spite of the limited impact in RNA binding affinity in vitro or RNA packaging in vivo that such mutations or structural alterations impart, they impair or abolish virus infectivity. It is likely that such an effect stems from the involvement of NCp7 in crucial steps of the virus life cycle other than RNA binding.
Copyright 1999 Academic Press.
Similar articles
- Anti-HIV agents that selectively target retroviral nucleocapsid protein zinc fingers without affecting cellular zinc finger proteins.
Huang M, Maynard A, Turpin JA, Graham L, Janini GM, Covell DG, Rice WG. Huang M, et al. J Med Chem. 1998 Apr 23;41(9):1371-81. doi: 10.1021/jm9708543. J Med Chem. 1998. PMID: 9554870 - Structural investigation on the requirement of CCHH zinc finger type in nucleocapsid protein of human immunodeficiency virus 1.
Ramboarina S, Morellet N, Fournié-Zaluski MC, Roques BP. Ramboarina S, et al. Biochemistry. 1999 Jul 27;38(30):9600-7. doi: 10.1021/bi9905258. Biochemistry. 1999. PMID: 10423237 - Effects of temperature on the dynamic behaviour of the HIV-1 nucleocapsid NCp7 and its DNA complex.
Ramboarina S, Srividya N, Atkinson RA, Morellet N, Roques BP, Lefèvre JF, Mély Y, Kieffer B. Ramboarina S, et al. J Mol Biol. 2002 Feb 22;316(3):611-27. doi: 10.1006/jmbi.2001.5379. J Mol Biol. 2002. PMID: 11866521 - HIV-1 gag proteins: diverse functions in the virus life cycle.
Freed EO. Freed EO. Virology. 1998 Nov 10;251(1):1-15. doi: 10.1006/viro.1998.9398. Virology. 1998. PMID: 9813197 Review. - Structure, biological functions and inhibition of the HIV-1 proteins Vpr and NCp7.
Roques BP, Morellet N, de Rocquigny H, Déméné H, Schueler W, Jullian N. Roques BP, et al. Biochimie. 1997 Nov;79(11):673-80. doi: 10.1016/s0300-9084(97)83501-8. Biochimie. 1997. PMID: 9479450 Review.
Cited by
- Overview of the Nucleic-Acid Binding Properties of the HIV-1 Nucleocapsid Protein in Its Different Maturation States.
Mouhand A, Pasi M, Catala M, Zargarian L, Belfetmi A, Barraud P, Mauffret O, Tisné C. Mouhand A, et al. Viruses. 2020 Sep 29;12(10):1109. doi: 10.3390/v12101109. Viruses. 2020. PMID: 33003650 Free PMC article. Review. - Dynamics of linker residues modulate the nucleic acid binding properties of the HIV-1 nucleocapsid protein zinc fingers.
Zargarian L, Tisné C, Barraud P, Xu X, Morellet N, René B, Mély Y, Fossé P, Mauffret O. Zargarian L, et al. PLoS One. 2014 Jul 16;9(7):e102150. doi: 10.1371/journal.pone.0102150. eCollection 2014. PLoS One. 2014. PMID: 25029439 Free PMC article. - Differential contribution of basic residues to HIV-1 nucleocapsid protein's nucleic acid chaperone function and retroviral replication.
Wu H, Mitra M, Naufer MN, McCauley MJ, Gorelick RJ, Rouzina I, Musier-Forsyth K, Williams MC. Wu H, et al. Nucleic Acids Res. 2014 Feb;42(4):2525-37. doi: 10.1093/nar/gkt1227. Epub 2013 Nov 28. Nucleic Acids Res. 2014. PMID: 24293648 Free PMC article. - Post-translational intracellular trafficking determines the type of immune response elicited by DNA vaccines expressing Gag antigen of Human Immunodeficiency Virus Type 1 (HIV-1).
Wallace A, West K, Rothman AL, Ennis FA, Lu S, Wang S. Wallace A, et al. Hum Vaccin Immunother. 2013 Oct;9(10):2095-102. doi: 10.4161/hv.26009. Epub 2013 Aug 13. Hum Vaccin Immunother. 2013. PMID: 23941868 Free PMC article. - Distinct binding interactions of HIV-1 Gag to Psi and non-Psi RNAs: implications for viral genomic RNA packaging.
Webb JA, Jones CP, Parent LJ, Rouzina I, Musier-Forsyth K. Webb JA, et al. RNA. 2013 Aug;19(8):1078-88. doi: 10.1261/rna.038869.113. Epub 2013 Jun 24. RNA. 2013. PMID: 23798665 Free PMC article.